Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Hemex Team Press Release
HEMEX opens subsidiary in Belgium, expanding its presence in the EU
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
2020 Swiss Innovation Challenge – the traditional networking kick-off event for the SIC was held virtually due to COVID-19 crisis on April 2, 2020! Numerous entrepreneurs from Switzerland and other European countries attended the online kick-off for this years challenge. 100 start-ups from all categories will be admitted to the first pitch, but only 50 […]
Inura Medical AG is admitted to participate at the 2020 >>venture>> competition! Inura Medical AG is a Swiss start-up company focused on the development of re-purposed urological products that combine a medical technology consisting of an urethral suppository and a pharmaceutical agent. Its first product offers a rescue therapy to two highly prevalent and disabling […]
Funding, Innovation
Scailyte announces its new advisory board composed of world leading clinicians and scientists
Scailyte™ is an ETH Zürich Spin-off and Top100 Swiss Startup applying artificial intelligence to discover novel and ultra-sensitive biomarkers from single-cell data.Over the past 3 years, we have established ScaiVision™, a proprietary data analytics platform for clinical research, which enables us to achieve groundbreaking discoveries in multiple disease areas. We have validated our approach by […]
After the Top 60 selection day for the W.A. De Vigier Award on February. Today the Top 16 were published. In the coming weeks the W.A. de Vigier jury will select the Top 10, based on expert reports, business plans, assessments and another presentation the winners will be announced at our Award Ceremony on June […]
Resistell AG has today closed an oversubscribed series A financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s fastest phenotypic antibiotic susceptibility test. Antimicrobial resistance (AMR) is one of the biggest global health challenges today. The emergence of multi-drug resistant pathogens has […]
The W.A. de Vigier Award is the oldest and highest endowed prize for startups in Switzerland, giving away five awards of CHF 100’000 each. Applications are open until January 6th. Since 1989, the foundation has distributed over CHF 11 million of seed money, resulting in more than 90 thriving Swiss startups, successful IPOs, multiple company […]